Bleeding Complication of Triple Therapy of Rivaroxaban, Prasugrel, and Aspirin : A Case Report and General Discussion

Hemorrhagic side effects are the bane of oral anticoagulation. Despite careful selection of medications and close monitoring, some adverse events are unavoidable. The available literature about the risks of triple oral anticoagulation therapy versus dual antiplatelet therapy does not address all of...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in cardiology 2014-01, Vol.2014 (2014), p.1-4
Main Authors: Alsara, Osama, Gruenebaum, Dane D., Laird-Fick, Heather S., Alsarah, Ahmad
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hemorrhagic side effects are the bane of oral anticoagulation. Despite careful selection of medications and close monitoring, some adverse events are unavoidable. The available literature about the risks of triple oral anticoagulation therapy versus dual antiplatelet therapy does not address all of the medication combinations currently available. This report describes a patient with atrial fibrillation and recent stent placement who developed severe, recurrent epistaxis on aspirin, prosugrel, and rivaroxaban. We believe this is the first case report of severe bleeding with this combination, and it may help provide insights into the risk for other patients.
ISSN:2090-6404
2090-6412
DOI:10.1155/2014/293476